4 Recruiting Lymphoma Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Lymphoma studiesPhase 1 / Phase 2 Studies for Lymphoma
🔵 Active, Not Recruiting Phase1 / Phase2
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
📍 Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill — Chapel Hill, North Carolina
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
📍 Research Site — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔